Trubion Pharmaceuticals, Inc. Overview

State:Washington
Country:United States
Industry:Biotechnology and Drugs
Description:
Trubion Pharmaceuticals, Inc. (Trubion) is a biopharmaceutical company creating a pipeline of protein therapeutic product candidates to treat autoimmune and inflammatory diseases, and cancer. The Company’s product development efforts are focused on three technologies: Small Modular Immunopharmaceutical (SMIP), protein therapeutics, SCORPION protein therapeutics, and TRU-ADhanCe potency enhancing technology for immunopharmaceuticals. As of December 31, 2009, the Company’s clinical-stage therapeutics target specific antigens on B cells, CD20 and CD37, and are designed using its custom drug assembly technology. Trubion lead product candidate, TRU-015, which the Company is developing with its partner, Pfizer Inc. (Pfizer), has completed a... (More)

Get Trial Access to OneSource

Company profiles, executive contacts, industry research, and news for sales, marketing and research professionals.

Disclaimer: While the OneSource Subscription Service maintains the freshest, most accurate data possible, this free site is refreshed on a periodic basis and may occasionally contain information that is not current. If you would like to alert us to a change, please email us, and we will take steps to make sure your update is included as soon as possible

Trubion Pharmaceuticals, Inc. Overview

Get Trial Access to OneSource

Business Information

Executive Profiles

Company Lists